WO2009053628A3 - Nouveaux composes, préparation et utilisations - Google Patents

Nouveaux composes, préparation et utilisations Download PDF

Info

Publication number
WO2009053628A3
WO2009053628A3 PCT/FR2008/051838 FR2008051838W WO2009053628A3 WO 2009053628 A3 WO2009053628 A3 WO 2009053628A3 FR 2008051838 W FR2008051838 W FR 2008051838W WO 2009053628 A3 WO2009053628 A3 WO 2009053628A3
Authority
WO
WIPO (PCT)
Prior art keywords
novel compounds
preparation
relates
present
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2008/051838
Other languages
English (en)
Other versions
WO2009053628A2 (fr
Inventor
Gaetan Lucien Alfred Mislin
Isabelle Jeanne Louise Schalk
Gerard Jean Marie Lescoat
Francois Remi Gaboriau
David Rodriguez-Lucena
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite de Strasbourg
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite de Strasbourg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM, Universite de Strasbourg filed Critical Centre National de la Recherche Scientifique CNRS
Publication of WO2009053628A2 publication Critical patent/WO2009053628A2/fr
Publication of WO2009053628A3 publication Critical patent/WO2009053628A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne de nouveaux composés, les compositions pharmaceutiques les comprenant ainsi que leurs applications thérapeutiques dans les domaines de la santé humaine et animale. La présente invention a également trait à un procédé de préparation de ces composés.
PCT/FR2008/051838 2007-10-11 2008-10-10 Nouveaux composes, préparation et utilisations Ceased WO2009053628A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0758229A FR2922210A1 (fr) 2007-10-11 2007-10-11 Nouveaux composes, preparation et utilisations
FR0758229 2007-10-11

Publications (2)

Publication Number Publication Date
WO2009053628A2 WO2009053628A2 (fr) 2009-04-30
WO2009053628A3 true WO2009053628A3 (fr) 2009-06-18

Family

ID=39281755

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/051838 Ceased WO2009053628A2 (fr) 2007-10-11 2008-10-10 Nouveaux composes, préparation et utilisations

Country Status (2)

Country Link
FR (1) FR2922210A1 (fr)
WO (1) WO2009053628A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201910900T4 (tr) 2005-04-04 2019-08-21 Univ Florida Desferritiyokin polieter analogları.
WO2008115433A1 (fr) 2007-03-15 2008-09-25 University Of Florida Analogues de polyéther de desferrithiocine
GB0918722D0 (en) 2009-10-26 2009-12-09 Univ Birmingham Anti cancer agent
EP3620161A1 (fr) 2011-12-16 2020-03-11 University of Florida Research Foundation, Inc. Utilisation d'analogues de 4'-desferrithiocine
AU2014352780A1 (en) 2013-11-22 2016-06-09 University Of Florida Research Foundation, Inc. Desferrithiocin analogs and uses thereof
WO2015077652A1 (fr) * 2013-11-22 2015-05-28 University Of Florida Research Foundation, Inc. Analogues de la désazadesferrithiocine et leurs utilisations
KR20170140306A (ko) 2015-04-27 2017-12-20 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 대사적으로 프로그램화된 금속 킬레이트화제 및 그의 용도

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005034949A1 (fr) * 2003-09-09 2005-04-21 University Of Florida Derives de desferrithiocine et leur utilisation en tant que chelateurs du fer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1585639A (zh) * 1998-09-21 2005-02-23 佛罗里达大学研究基金会 抗疟疾制剂

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005034949A1 (fr) * 2003-09-09 2005-04-21 University Of Florida Derives de desferrithiocine et leur utilisation en tant que chelateurs du fer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HOVEYDA H R ET AL: "DESIGN AND SYNTHESIS OF MULTIDENTATE 2-(2'-HYDROXYPHENYL)-2-THIAZOLI NES FOR BIOMEDICAL APPLICATION", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 48, no. 25, 1992, pages 5219 - 5226, XP001160881, ISSN: 0040-4020 *

Also Published As

Publication number Publication date
FR2922210A1 (fr) 2009-04-17
WO2009053628A2 (fr) 2009-04-30

Similar Documents

Publication Publication Date Title
WO2008087367A3 (fr) Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
WO2010069532A8 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
WO2008012470A3 (fr) Derives d'imidazolones substitues, preparation et utilisations
IL212435A (en) Isoindulin compounds, their pharmaceutical compositions and their use in the preparation of drugs
WO2007118963A3 (fr) Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
ZA200805939B (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL208203A (en) Annotations of 3,2-Dihydro-Pyrido-4,1-Exazine and 3,2-Dihydro-4-Oxa-9,1-Diazapananthrene, Preparation Processes and Pharmaceutical Preparations
IL189008A (en) History of 1-Naphthalenyl-3-azabicyclo [0.1.3] hexane
WO2009129246A3 (fr) Compositions et leurs procédés de préparation et d'utilisation
IL193341A0 (en) Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
IL193339A0 (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL195813A0 (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
WO2010021607A3 (fr) Préparation pharmaceutique
WO2008087366A3 (fr) Derives de 3-phenyl-1-(phenylthienyl)propan-1-one et de 3-phenyl-1-(phenylfuranyl)propan-1-one substitues, preparation et utilisation
IL213452A0 (en) Phenylpyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof
WO2009053628A3 (fr) Nouveaux composes, préparation et utilisations
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2008087365A3 (fr) Derives de 1,3-diphenylpropane substitues, preparations et utilisations
ZA200900237B (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
PT2231598E (pt) Novos derivados diazéniodiolato, processo para a sua preparação e as composições farmacêuticas que os contenham
EP2196463A4 (fr) Procédé de préparation d'acide 5,6-diméthylxanthone-acétique, dérivés ainsi obtenus et formulations pharmaceutiques de ceux-ci
IL190596A0 (en) 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
ZA201000520B (en) Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
EP1916251A4 (fr) Sels d érianine, leurs procédés de préparation et compositions pharmaceutiques contenant ceux-ci

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08841252

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08841252

Country of ref document: EP

Kind code of ref document: A2